Hodgkin lymphoma trials in Canada

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

  Where

  Calgary, Winnipeg

  Age

  18 years and over

  People

  130 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT06806033 · EU 2024-516791-15-00
• Phase 1/2Taking people
  A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

  Where

  Montreal, Toronto

  Age

  18 years and over

  People

  280 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07519772 · EU 2025-523005-15-00
• Phase 2Taking people
  Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  Where

  Barrie, Brampton, Ottawa, Toronto

  Age

  18 years and over

  People

  270 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06526793 · EU 2023-505789-27-00
• Phase 3Taking people
  Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

  Where

  Halifax, Hamilton, Ottawa, Saint John, Toronto, Vancouver, Winnipeg

  Age

  16 years to 69 years

  People

  1,042 worldwide

  Run by

  University College, London

  See details and how to joinNCT04685616 · EU 2022-500031-37-00
• Phase 2Taking people
  Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

  Where

  Calgary, Halifax, Hamilton, London, Montreal, Ottawa, Regina, Sherbrooke, St. John's, Toronto, Vancouver

  Age

  18 years and over

  People

  84 worldwide

  Run by

  Canadian Cancer Trials Group

  See details and how to joinNCT05180097